Ozempic®: a new therapeutic option for type 2 diabetes patients

被引：0
|
作者：
Coquard-Schmidt, Barbara
机构：
来源：
CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION | 2019年 / 23卷 / 4-5期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：139 / 139
页数：1
相关论文
共 50 条
  • [1] Neprilysin inhibition: a new therapeutic option for type 2 diabetes?
    Nathalie Esser
    Sakeneh Zraika
    Diabetologia, 2019, 62 : 1113 - 1122
  • [2] Neprilysin inhibition: a new therapeutic option for type 2 diabetes?
    Esser, Nathalie
    Zraika, Sakeneh
    DIABETOLOGIA, 2019, 62 (07) : 1113 - 1122
  • [3] Semaglutide (Ozempic) for Type 2 Diabetes Mellitus
    Chamberlin, Shaunta
    Dabbs, William
    AMERICAN FAMILY PHYSICIAN, 2019, 100 (02) : 116 - 117
  • [4] PYY, a Therapeutic Option for Type 2 Diabetes?
    Guida, Claudia
    Ramracheya, Reshma
    CLINICAL MEDICINE INSIGHTS-ENDOCRINOLOGY AND DIABETES, 2020, 13
  • [5] AN UPDATE ON EXENATIDE, A NOVEL THERAPEUTIC OPTION FOR PATIENTS WITH TYPE 2 DIABETES
    Crasto, W.
    Khunti, K.
    Davies, M. J.
    DRUGS OF TODAY, 2011, 47 (11) : 839 - 856
  • [6] Glyburide/metformin tablets: a new therapeutic option for the management of Type 2 diabetes
    Dailey, GE
    EXPERT OPINION ON PHARMACOTHERAPY, 2003, 4 (08) : 1417 - 1430
  • [7] Incretin mimetics: a novel therapeutic option for patients with type 2 diabetes - a review
    Hansen, Katrine B.
    Vilsboll, Tina
    Knop, Filip K.
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2010, 3 : 155 - 163
  • [8] EMPAGLIFLOZIN: A NEW TREATMENT OPTION FOR PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Dailey, G. E.
    DRUGS OF TODAY, 2015, 51 (09) : 519 - 535
  • [9] Fasiglifam as a new potential treatment option for patients with type 2 diabetes
    Kaku, Kohei
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (18) : 2591 - 2600
  • [10] Higher-Dose Semaglutide (Ozempic) for Type 2 Diabetes
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2022, 64 (1650): : 79 - 79
12345